Page last updated: 2024-08-21

hydrazine and Cardiomyopathy, Congestive

hydrazine has been researched along with Cardiomyopathy, Congestive in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hatano, M; Hibiya, K; Ichikawa, M; Nagasawa, M; Ozawa, Y; Saito, S; Tamura, Y; Tomobe, K; Yumikura, S	1
Badorff, C; Dimmeler, S; Fichtlscherer, B; Knowlton, KU; Muelsch, A; Rhoads, RE; Zeiher, AM	1

Other Studies

2 other study(ies) available for hydrazine and Cardiomyopathy, Congestive

Article	Year
Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response. Japanese circulation journal, 1984, Volume: 48, Issue:4 Topics: Adult; Aged; Ambulatory Care; Cardiac Catheterization; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Hydrazines; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume; Todralazine	1984
Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy. Circulation, 2000, Oct-31, Volume: 102, Issue:18 Topics: Animals; Blotting, Western; Cardiomyopathy, Dilated; Catalytic Domain; COS Cells; Cysteine; Cysteine Endopeptidases; Densitometry; Dystrophin; Enterovirus Infections; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Hydrazines; Mice; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Penicillamine; Peptide Hydrolases; S-Nitroso-N-Acetylpenicillamine; Spermine; Sulfhydryl Compounds; Viral Fusion Proteins; Viral Proteins	2000

Article

Year

Ambulatory long-term vasodilator therapy for chronic refractory heart failure: hemodynamic evaluation and clinical response.

Japanese circulation journal, 1984, Volume: 48, Issue:4

Topics: Adult; Aged; Ambulatory Care; Cardiac Catheterization; Cardiomyopathy, Dilated; Chronic Disease; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Hydrazines; Isosorbide Dinitrate; Long-Term Care; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume; Todralazine

1984

Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through S-nitrosylation: A protective mechanism against enteroviral cardiomyopathy.

Circulation, 2000, Oct-31, Volume: 102, Issue:18

Topics: Animals; Blotting, Western; Cardiomyopathy, Dilated; Catalytic Domain; COS Cells; Cysteine; Cysteine Endopeptidases; Densitometry; Dystrophin; Enterovirus Infections; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Hydrazines; Mice; Nitric Oxide; Nitric Oxide Donors; Nitrogen Oxides; Penicillamine; Peptide Hydrolases; S-Nitroso-N-Acetylpenicillamine; Spermine; Sulfhydryl Compounds; Viral Fusion Proteins; Viral Proteins

2000